Cadila Pharma launches cholesterol drug Belmore
25 May 2022 | News
Bempedoic acid is a one-of-its-kind drug for the treatment of high LDL cholesterol or bad cholesterol
Ahmedabad-based Cadila Pharmaceuticals has launched a novel drug for the treatment of high LDL cholesterol for the first time in India.
To be sold under the brand name Belmore, Bempedoic acid is a one-of-its-kind drug for the treatment of high LDL (low-density lipoprotein) cholesterol, also known as bad cholesterol.
“Belmore (bempedoic acid) provides additional benefits to patients, and all pre-launch studies have established this advantage. Belmore is one more addition to our fast-growing portfolio of indigenous innovations. We are committed to continuing our journey of making affordable drugs available to everyone,” said Jawed Zia, CEO , Domestic Prescription Business, Cadila Pharmaceuticals.
